跳至主要内容
临床试验/NCT00653107
NCT00653107终止3 期

Palliation of Dysphagia in Patients With Advanced Cancer of the Oesophagus by Comparing Stent Followed by 3 Courses of Brachytherapy With 3 Courses of Brachytherapy Only. A Randomised Phase III Study (PACO)

Oslo University Hospital2 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2008年6月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
终止
发起方
入组人数
41
试验地点
2
主要终点
Dysphagia measured with the dysphagia grading scale at week +2 after start of treatment. Pain at rest measured with ESAS at week +2 after start of treatment.

研究概览

简要总结

We wish to improve the swallowing function of patients with advanced cancer of the oesophagus, by carrying out a randomised clinical study in which we compare primary stenting followed by brachytherapy in the stent, 8 G x 3 with standard brachytherapy 8 Gy x 3.

The aim of the study is to investigate whether patients who receive a stent followed by brachytherapy have a better swallowing function without more pain at week +2,compared to patients who receive brachytherapy alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must fulfill all the following criteria:
  • Histologically or cytologically verified carcinoma of the oesophagus
  • Reduced ability to swallow solid food, minimum grade 1 (see page 16)
  • Age ≥ 18 years
  • Ability to understand and answer (with or without help) the study questionnaires
  • Written informed consent received
  • A Completed questionnaire received from the patient
  • One of the following criteria must be fulfilled:
  • Advanced disease and WHO performance status ≥2
  • Advanced disease and WHO performance status 0-1 and other therapy excluded due to medical condition
  • Advanced disease and WHO performance status 0-1 and patient's preference
  • Local disease and WHO performance status ≥2 and other therapy excluded due to medical condition
  • Local disease and WHO performance status ≥2 and patient's preference

排除标准

  • Oesophageal stent already inserted
  • Endoscopic procedures not tolerated
  • Cannot have (additional) radiation therapy
  • Tumour location not suited for stent or brachytherapy (the upper 3 cm of oesophagus or major component in the cardia)

研究组 & 干预措施

B

Active Comparator

3 fractions of brachytherapy

干预措施: Brachytherapy (Radiation)

A

Experimental

Stent followed by 3 brachytherapy fractions

干预措施: Stent insertion (Procedure)

A

Experimental

Stent followed by 3 brachytherapy fractions

干预措施: Brachytherapy (Radiation)

结局指标

主要结局

Dysphagia measured with the dysphagia grading scale at week +2 after start of treatment. Pain at rest measured with ESAS at week +2 after start of treatment.

时间窗: 8 years

次要结局

  • Health related quality of life(8 years)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Cecilie Delphin Amdal

MD

Oslo University Hospital

研究点 (2)

Loading locations...

相似试验

Palliation Dysphagia Cancer Oesophagus... | 临床试验